Table 1 Baseline characteristics and demographics (N = 66).
From: Five-year follow-up with the PreserFlo MicroShunt for open-angle glaucoma
Age, years, mean ± SD | 65 ± 12 |
Gender, male (n) | 52% (34) |
Eye, right (n) | 50% (33) |
CCT, µm, mean ± SD | 532 ± 42 |
CDVA, LogMAR, mean ± SD | 0.18 ± 0.42 |
Pseudophakic (n) | 35% (23) |
Type of glaucoma (n) | |
POAG | 88% (58) |
Pigmentary glaucoma | 12% (8) |
Glaucoma severity (n) | |
Mild (MD, 0 to –6 dB) | 27% (17) |
Moderate (MD, –6 dB to –12 dB) | 30% (19) |
Advanced (MD, <–12 dB) | 43% (27) |
IOP, mmHg, mean ± SD | 21.8 ± 4.2 |
No. of IOP-lowering medication, mean ± SD | 2.5 ± 1.4 |
No. of IOP-lowering medication (n) | |
0 | 14% (9) |
1–2 | 32% (21) |
≥3 | 55% (36) |
Use of oral carbonic anhydrase inhibitors (n) | 11% (7) |
History of laser trabeculoplasty (n) | 38% (25) |
